Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.40 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 6/20 | 0.35 |
| ▸ | MAPT | P10636 | 5/20 | 0.35 |
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.35 |
| ▸ | BCHE | P06276 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 2/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 1/20 | 0.35 |
| ▸ | CNR1 | P21554 | 1/20 | 0.35 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29941097 | 1.00 | LMNA (0.40) | LMNAADORA3CHRM2KCNH2GAA | |
| SCHEMBL9332219 | 0.80 | LMNA (0.54) | LMNAADORA3CHRM2KCNH2GAA | |
| SCHEMBL29815212 | 0.80 | LMNA (0.54) | LMNAADORA3CHRM2KCNH2GAA | |
| SCHEMBL12027473 | 0.80 | CES1 (0.38) | — | |
| SCHEMBL21523316 | 0.79 | MEN1 (0.32) | LMNAADORA3GAAMAPTMEN1 | |
| SCHEMBL21940539 | 0.79 | PTPRC (0.41) | LMNAMAPTMEN1KMT2ATDP1 | |
| SCHEMBL20915076 | 0.79 | PDK2 (0.32) | PDK2PDK4 | |
| SCHEMBL20846857 | 0.78 | NPC1 (0.40) | GAAMAPTNOX1NPC1MAPK1 | |
| SCHEMBL22481656 | 0.74 | PDK2 (0.54) | LMNAADORA3CHRM2KCNH2GAA | |
| SCHEMBL9927262 | 0.73 | PTPRC (0.39) | LMNAMAPTMEN1KMT2ATDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10472564-B2 | Delayed fluorescence compound and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2019-11-12 | — | — | US | disclosed |
| US-10472564-B2 | Delayed fluorescence compound and organic electroluminescent device using the same | LUMINESCENCE TECHNOLOGY CORP. (TW) | 2019-11-12 | — | — | US | disclosed |
| US-20190093009-A1 | DELAYED FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2019-03-28 | — | — | US | disclosed |
| US-20190093009-A1 | DELAYED FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | LUMINESCENCE TECHNOLOGY CORPORATION (TW) | 2019-03-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10472564-B2 | Delayed fluorescence compound and organic electroluminescent device using the same | SLCO4C1, LEF1, SLCO2A1 | LMNA 1633/4885ADORA3 3069/4885CHRM2 3966/4885 |
| US-20190093009-A1 | DELAYED FLUORESCENCE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME | SLCO4C1, LEF1, SLCO2A1 | LMNA 1633/4885ADORA3 3069/4885CHRM2 3966/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.